RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)

NCT02801097 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Sufficient patients enrolled to end study

Conditions

Malignant Solid Tumor
Metastatic Cancer
Advanced Cancer

Interventions

DRUG: RRx-001
DRUG: Irinotecan

Sponsor

EpicentRx, Inc.